Fluorosulfate-containing pyrazole heterocycles as selective BuChE inhibitors: structure-activity relationship and biological evaluation for the treatment of Alzheimer’s disease

References

• Marikova J, Ritomska A, Korabecny J, et al. Aromatic esters of the crinane Amaryllidaceae alkaloid ambelline as selective inhibitors of butyrylcholinesterase. J Nat Prod 2020;83:1359–67.
   PubMed Web of Science ®Google Scholar
• Liu S, Dang M, Lei Y, et al. Ajmalicine and its analogues against AChE and BuChE for the management of Alzheimer's disease: an in-silico study. Curr Pharm Des 2020;26:4808–14.
   PubMed Web of Science ®Google Scholar
• Rossi M, Freschi M, de Camargo NL, et al. Sustainable drug discovery of multi-target-directed ligands for Alzheimer's disease. J Med Chem 2021;64:4972–90.
   PubMed Web of Science ®Google Scholar
• Alzheimer’s Disease International. https://www.alzint.org/about/dementia-facts-figures/dementia-statistics [accessed 24 Oct 2021].
   Google Scholar
• Ahuja-Casarin AI, Merino-Montiel P, Vega-Baez JL, et al. Tuning the activity of iminosugars: novel N-alkylated deoxynojirimycin derivatives as strong BuChE inhibitors. J Enzyme Inhib Med Chem 2021;36:138–46.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Guo J, Cheng M, et al. Design, synthesis, and biological evaluation of novel xanthone-alkylbenzylamine hybrids as multifunctional agents for the treatment of Alzheimer's disease. Eur J Med Chem 2021;213:113154.
   PubMed Web of Science ®Google Scholar
• Meden A, Knez D, Malikowska-Racia N, et al. Structure-activity relationship study of tryptophan-based butyrylcholinesterase inhibitors. Eur J Med Chem 2020;208:112766.
   PubMed Web of Science ®Google Scholar
• Miles JA, Kapure JS, Deora GS, et al. Rapid discovery of a selective butyrylcholinesterase inhibitor using structure-based virtual screening. Bioorg Med Chem Lett 2020;30:127609.
   PubMed Web of Science ®Google Scholar
• Topcu G, Akdemir A, Kolak U, et al. Anticholinesterase and antioxidant activities of natural abietane diterpenoids with molecular docking studies. Curr Alzheimer Res 2020;17:269–84.
   PubMed Web of Science ®Google Scholar
• Kandiah N, Pai MC, Senanarong V, et al. Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia. Clin Interv Aging 2017;12:697–707.
   PubMed Web of Science ®Google Scholar
• Greig NH, Utsuki T, Ingram DK, et al. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent. Proc Natl Acad Sci USA 2005;102:17213–8.
   PubMed Web of Science ®Google Scholar
• Mansha M, Taha M, Hassane Anouar E, Ullah N. The design of fluoroquinolone-based cholinesterase inhibitors: synthesis, biological evaluation and in silico docking studies. Arab J Chem 2021;14:103211.
   Web of Science ®Google Scholar
• Zhao W, Zheng S, Zou J, et al. Synthesis of novel pesticidal N,N'-disubstituted sulfamide derivatives using sulfur(VI) fluorine exchange click reaction. J Agric Food Chem 2021;69:5798–803.
   PubMed Web of Science ®Google Scholar
• Masson P, Lockridge O. Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior. Arch Biochem Biophys 2010;494:107–20.
   PubMed Web of Science ®Google Scholar
• Xu M, Peng Y, Zhu L, et al. Triazole derivatives as inhibitors of Alzheimer's disease: current developments and structure-activity relationships. Eur J Med Chem 2019;180:656–72.
   PubMed Web of Science ®Google Scholar
• de Andrade RG, Souza DOA, Bartolini M, et al. Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties. RSC Med Chem 2021;12:1154–63.
   PubMedGoogle Scholar
• Mesulam MM, Geula C. Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia. Ann Neurol 1994;36:722–7.
   PubMed Web of Science ®Google Scholar
• Bortolami M, Pandolfi F, De Vita D, et al. New deferiprone derivatives as multi-functional cholinesterase inhibitors: design, synthesis and in vitro evaluation. Eur J Med Chem 2020;198:112350.
   PubMed Web of Science ®Google Scholar
• Contestabile A. The history of the cholinergic hypothesis. Behav Brain Res 2011;221:334–40.
   PubMed Web of Science ®Google Scholar
• Li Q, He S, Chen Y, et al. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease. Eur J Med Chem 2018;158:463–77.
   PubMed Web of Science ®Google Scholar
• Xing S, Li Q, Xiong B, et al. Structure and therapeutic uses of butyrylcholinesterase: application in detoxification, Alzheimer's disease, and fat metabolism. Med Res Rev 2021;41:858–901.
   PubMed Web of Science ®Google Scholar
• Dong J, Krasnova L, Finn MG, et al. Sulfur(VI) fluoride exchange (SuFEx): another good reaction for click chemistry. Angew Chem Int Ed Engl 2014;53:9430–48.
   PubMed Web of Science ®Google Scholar
• Moku B, Fang WY, Leng J, et al. Rh-catalyzed highly enantioselective synthesis of aliphatic sulfonyl fluorides. iScience 2019;21:695–705.
   PubMed Web of Science ®Google Scholar
• Qin H, Zheng Q, Bare GAL, et al. A Heck–Matsuda process for the synthesis of β-arylethenesulfonyl fluorides: selectively addressable bis-electrophiles for SuFEx click chemistry. Angew Chem Int Ed Engl 2016;55:14155–8.
   PubMed Web of Science ®Google Scholar
• Barrow AS, Smedley CJ, Zheng Q, et al. The growing applications of SuFEx click chemistry. Chem Soc Rev 2019;48:4731–58.
   PubMed Web of Science ®Google Scholar
• Chen X, Zha GF, Fang WY, et al. A portal to a class of novel sultone-functionalized pyridines via an annulative SuFEx process employing earth abundant nickel catalysts. Chem Commun (Camb) 2018;54:9011–4.
   PubMed Web of Science ®Google Scholar
• Kulow RW, Wu JW, Kim C, et al. Synthesis of unsymmetrical sulfamides and polysulfamides via SuFEx click chemistry. Chem Sci 2020;11:7807–12.
   PubMed Web of Science ®Google Scholar
• Li S, Wu P, Moses JE, et al. Multidimensional SuFEx click chemistry: sequential sulfur(VI) fluoride exchange connections of diverse modules launched from an SOF4 hub. Angew Chem Int Ed Engl 2017;56:2903–8.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wu C, Chen X, et al. Novel pyridine-containing sultones: structure-activity relationship and biological evaluation as selective AChE inhibitors for the treatment of Alzheimer's disease. ChemMedChem 2021;16:3189–200.
   PubMed Web of Science ®Google Scholar
• Mahapatra S, Woroch CP, Butler TW, et al. SuFEx activation with Ca(NTf2)2: a unified strategy to access sulfamides, sulfamates, and sulfonamides from S(VI) fluorides. Org Lett 2020;22:4389–94.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhao X, Cappiello JR, et al. Identification of simple arylfluorosulfates as potent agents against resistant bacteria. Proc Natl Acad Sci U S A 2021; 118:e2103513118.
   PubMed Web of Science ®Google Scholar
• Zha GF, Wang SM, Rakesh KP, et al. Discovery of novel arylethenesulfonyl fluorides as potential candidates against methicillin-resistant of Staphylococcus aureus (MRSA) for overcoming multidrug resistance of bacterial infections. Eur J Med Chem 2019;162:364–77.
   PubMed Web of Science ®Google Scholar
• Kitamura S, Zheng Q, Woehl JL, et al. Sulfur(VI) fluoride exchange (SuFEx)-enabled high-throughput medicinal chemistry. J Am Chem Soc 2020;142:10899–904.
   PubMed Web of Science ®Google Scholar
• Zheng Q, Woehl JL, Kitamura S, et al. SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase. Proc Natl Acad Sci U S A 2019;116:18808–14.
   PubMed Web of Science ®Google Scholar
• Leng J, Qin HL. SO2F2 mediated transformation of pyrazolones into pyrazolyl fluorosulfates. Org Biomol Chem 2019;17:5001–8.
   PubMed Web of Science ®Google Scholar
• Pourabdi L, Khoobi M, Nadri H, et al. Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE/BuChE and 15-LOX. Eur J Med Chem 2016;123:298–308.
   PubMed Web of Science ®Google Scholar
• Jalili-Baleh L, Nadri H, Moradi A, et al. New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease. Eur J Med Chem 2017;139:280–9.
   PubMed Web of Science ®Google Scholar
• Chen X, Zha GF, Wang JQ, et al. Ethenesulfonyl fluoride derivatives as telomerase inhibitors: structure-based design, SAR, and anticancer evaluation in vitro. J Enzyme Inhib Med Chem 2018;33:1266–70.
   PubMed Web of Science ®Google Scholar
• Qiu GL, He SS, Chen SC, et al. Design, synthesis and biological evaluation of tricyclic pyrazolo[1,5-c][1,3]benzoxazin-5(5H)-one scaffolds as selective BuChE inhibitors. J Enzyme Inhib Med Chem 2018;33:1506–15.
   PubMed Web of Science ®Google Scholar
• Devraj K, Guérit S, Macas J, et al. An in vivo blood-brain barrier permeability assay in mice using fluorescently labeled tracers. J Vis Exp 2018;132:57038.
   Google Scholar
• Bergmann S, Lawler SE, Qu Y, et al. Blood-brain-barrier organoids for investigating the permeability of CNS therapeutics. Nat Protoc 2018;13:2827–43.
   PubMed Web of Science ®Google Scholar
• Viayna E, Coquelle N, Cieslikiewicz-Bouet M, et al. Discovery of a potent dual inhibitor of acetylcholinesterase and butyrylcholinesterase with antioxidant activity that alleviates alzheimer-like pathology in old APP/PS1 mice. J Med Chem 2021;64:812–39.
   PubMed Web of Science ®Google Scholar
• Nagar S, Argikar UA, Tweedie DJ. Enzyme kinetics in drug metabolism: fundamentals and applications. Methods Mol Biol 2014;1113:1–6.
   PubMedGoogle Scholar
• Larik FA, Shah MS, Saeed A, et al. New cholinesterase inhibitors for Alzheimer's disease: structure activity relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives. Int J Biol Macromol 2018;116:144–50.
   PubMed Web of Science ®Google Scholar
• Larik FA, Saeed A, Faisal M, et al. Synthesis, inhibition studies against AChE and BChE, drug-like profiling, kinetic analysis and molecular docking studies of N-(4-phenyl-3-aroyl-2(3H)-ylidene) substituted acetamides. J Mol Struct 2020;1203:127459.
   Web of Science ®Google Scholar
• Choi JM, Oh SJ, Lee SY, et al. HepG2 cells as an in vitro model for evaluation of cytochrome P450 induction by xenobiotics. Arch Pharm Res 2015; 38:691–704.
   PubMed Web of Science ®Google Scholar
• Hajialyani M, Hosein FM, Echeverria J, et al. Hesperidin as a neuroprotective agent: a review of animal and clinical evidence. Molecules 2019;24:648.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang L, Liu D, et al. Neuroprotective effects of extracts from the radix Curcuma aromatica on H2O2-induced damage in PC12 cells. Comb Chem High Throughput Screen 2018;21:571–82.
   PubMed Web of Science ®Google Scholar
• Li Q, Xing S, Chen Y, et al. Discovery and biological evaluation of a novel highly potent selective butyrylcholinsterase inhibitor. J Med Chem 2020;63:10030–44.
   PubMed Web of Science ®Google Scholar
• Di L, Kerns EH, Bezar IF, et al. Comparison of blood-brain barrier permeability assays: in situ brain perfusion, MDR1-MDCKII and PAMPA-BBB. J Pharm Sci 2009;98:1980–91.
   PubMed Web of Science ®Google Scholar
• Dighe SN, Deora GS, De la Mora E, et al. Discovery and structure-activity relationships of a highly selective butyrylcholinesterase inhibitor by structure-based virtual screening. J Med Chem 2016;59:7683–9.
   PubMed Web of Science ®Google Scholar
• Mehla J, Deibel SH, Faraji J, et al. Looking beyond the standard version of the Morris water task in the assessment of mouse models of cognitive deficits. Hippocampus 2019;29:3–14.
   PubMed Web of Science ®Google Scholar
• Berkowitz LE, Harvey RE, Drake E, et al. Progressive impairment of directional and spatially precise trajectories by TgF344-Alzheimer's disease rats in the Morris Water Task. Sci Rep 2018;8:16153.
   PubMed Web of Science ®Google Scholar
• Bromley-Brits K, Deng Y, Song W. Morris water maze test for learning and memory deficits in Alzheimer's disease model mice. J Vis Exp 2011;53:2920.
   Google Scholar